Smartlab Europe

Press Releases

Greenphire Announces Strategic Growth Investment from Thoma Bravo

Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, announced that it has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The...

Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb

Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company. This expanded collaboration has the potential to add to the Bristol Myers Squibb drug pipeline whilst enhancing...

LATAM Cargo Group collaborates with SkyCell to bring hybrid to South America’s pharma market

Fulfilling our mission to deliver medicine to all means shipping pharma products to remote and infrastructurally challenging environments across the world. With our hybrid containers engineered and designed to safeguard cargo in the most extreme conditions, our solution is...

MedPharm Announces Expansion of Formulation Development and Analytical Service Labs in the UK

MedPharm Ltd, the world leader in formulation development and analytical services for topical and transdermal products, is thrilled to announce a £1.5M investment into the refurbishment and expansion of our 15,000 sq ft campus in Surrey, UK that will increase our UK laboratory...

Roche’s Antibody Cocktail is now available in India, Cipla to market it pan-India

Roche India and Cipla Limited announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June. In total they can potentially benefit 200,000...

AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan

AstraZeneca’s COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals aged 18 years and older, to prevent COVID-19 caused by SARS-CoV-2. The Japanese Ministry of Health,...

UPS Healthcare Accelerates Cold Chain Capabilities

UPS is expanding its specialty pharmaceutical offerings by establishing UPS Cold Chain Solutions, a comprehensive suite of cold chain technologies, best-in-class capabilities, and new and expanded global facilities providing complete, end-to-end temperature-controlled logistics. “Our customers have been taking advantage of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »